Navigation Links
Insmed Announces Financial Results for Second Quarter and Six-Months Ended June 30, 2008
Date:8/8/2008

8 3,682

Long-term liabilities:

Convertible debt 1,658 2,764

Debt discount (312) (651)

Net long-term convertible debt 1,346 2,113

Asset retirement obligation 2,217 2,217

Total liabilities 9,261 8,012

Stockholders' equity:

Common stock; $.01 par value; authorized

shares 500,000,000; issued and

outstanding shares, 122,305,635 in 2008

and 121,904,312 in 2007 1,223 1,219

Additional paid-in capital 341,771 341,270

Accumulated deficit (340,299) (330,759)

Accumulated other comprehensive loss:

Unrealized loss on investment - (242)

Net stockholders' equity 2,695 11,488

Total liabilities and stockholders'

equity $11,956 $19,500

INSMED INCORPORATED

Consolidated Statements of Operations

(in thousands, except per share data - unaudited)

Three Months Ended Six Months Ended

June 30, June 30,

2008 2007 2008 2007

Sales, net $- $- $- $423

Royalties 29 17 54 52

License income - 1,045 - 1,545

Other expanded access

program income 2,619 1,213 4,911 1,915

Total revenues 2,648 2,275 4,965 3,935

Operating expenses:

Cost of goods sold
'/>"/>

SOURCE Insmed Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related biology technology :

1. Insmed Appoints Dennis M. Lanfear to Board Of Directors
2. Insmed Awarded $2.1 Million by Muscular Dystrophy Association
3. Insmed to Appeal Delisting Notification From Nasdaq
4. Insmed President Interviewed for Follow-On Biologics Podcast: Insmed Inc. President Steve Glover Discusses Safe and Effective Biologic Therapies and Reduced Costs with The American Magazine
5. Insmed CEO Issues Statement on White House FY09 Budget and FDA Statements on Follow-On Biologics
6. Insmed to Host Fourth Quarter and Full-Year 2007 Conference Call
7. Insmed Announces Listing Transfer from Nasdaq Global Market to Nasdaq Capital Market
8. Insmed Announces Fourth Quarter and Full-Year 2007 Financial Results
9. Insmed Announces Additional Information in Compliance With NASDAQ Rules
10. Insmed Selected to Complete Congressional Questionnaire Regarding the Potential Establishment of a Follow-On Biologics Regulatory Pathway
11. Insmed to Present at CBI Follow-On Biologics Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2015)... , Sep. 02, 2015 ... announced the addition of Jain PharmaBiotech,s new report ... to their offering. This report follows ... characteristic that can be objectively measured and evaluated ... processes as well as pharmacological responses to a ...
(Date:9/2/2015)... , Sept. 2, 2015  Neurotech Pharmaceuticals, Inc., ... in the multicenter Phase 2 clinical trial of ... treatment of recurrent subfoveal choroidal neovascularization secondary to ... a unique vascular endothelial growth factor (VEGF) receptor ... "This landmark proof-of-concept study will evaluate ...
(Date:9/2/2015)... , September 2, 2015 BiondVax ... of the National Institute of Allergy and Infectious Diseases (NIAID), ... the Department of Health and Human Services (HHS), to launch ... the United States in the 2015-16 timeframe. ... vaccine candidate, Multimeric-001 (M-001), as a primer vaccine, which would ...
(Date:9/2/2015)... ... September 02, 2015 , ... The ... creating professional commercial video content, to analysis of athletic performance. Producing high-resolution ... go by too quickly to process with the naked eye. , Slow ...
Breaking Biology Technology:Updated 2015 Biomarkers Report - Latest Technologies, Markets and Companies Insights to 2024 with over 1,000 References 2Updated 2015 Biomarkers Report - Latest Technologies, Markets and Companies Insights to 2024 with over 1,000 References 3Neurotech Announces First Patient Enrolled in Novel Anti-VEGF Encapsulated Cell Therapy Study 2Neurotech Announces First Patient Enrolled in Novel Anti-VEGF Encapsulated Cell Therapy Study 3Neurotech Announces First Patient Enrolled in Novel Anti-VEGF Encapsulated Cell Therapy Study 4BiondVax Announces Intent to Launch a Phase 2 Trial in the United States in Collaboration with the U.S. National Institutes of Health 2BiondVax Announces Intent to Launch a Phase 2 Trial in the United States in Collaboration with the U.S. National Institutes of Health 3Fastec Introduces the Quad-HD TS5-Q High-Speed Camera 2Fastec Introduces the Quad-HD TS5-Q High-Speed Camera 3
... Fiber Reduces Bacteria to Levels below Detection; Can ... Provide Permanent Protection in Everyday Products, HAMPTON, N.H., ... successfully embed a natural balance of silver and copper,into ... 99.99 percent effective in killing methicillin-resistant Staphylococcus,aureus (MRSA) bacteria ...
... and The University of Texas at Austin are two ... $1.4 million from the National Science Foundation. The ... explore ways of concentrating optical energy on a scale ... for applications in nanoscience and nanotechnology. , NIRT Consortium ...
... AMSTERDAM, October 29 Agendia BV, ... of cancer molecular diagnostics has appointed six,members ... The newly,established Clinical and Scientific Advisory Board ... clinical expertise.,The advisors review early research programs ...
Cached Biology Technology:Innovative Fosshield(R) Antimicrobial Technology Shown to Continuously Kill MRSA 'Superbug' 2Innovative Fosshield(R) Antimicrobial Technology Shown to Continuously Kill MRSA 'Superbug' 3Innovative Fosshield(R) Antimicrobial Technology Shown to Continuously Kill MRSA 'Superbug' 4Innovative Fosshield(R) Antimicrobial Technology Shown to Continuously Kill MRSA 'Superbug' 5UTSA/UT lead national nanoscience consortium 2Agendia BV Appoints Clinical and Scientific Advisory Board 2
(Date:8/31/2015)... , August 31, 2015 Growing ... technology in government digitization projects to drive India ... recently published TechSci Research report, " India Biometrics Market Forecast ... is projected to grow at a CAGR of ... is anticipated on account of extensive use of biometric technology ...
(Date:8/28/2015)... 28, 2015 According to a ... by Assessment Type (Pen & Paper Based, Hosted, Biometrics), ... Learning, Academic Research), Vertical and Region - Global Forecast ... Market to grow from USD 2.4 Billion in 2015 ... Annual Growth Rate (CAGR) of 25.6% from 2015 to ...
(Date:8/25/2015)... and BELLEVUE, Wash. , Aug. 25, ... robotic systems, announced today it will unveil its "Guardian ... (UGV), at the National Tactical Officers Association Conference on ... The Guardian S is the first-ever commercially available energetically ... of research and in-field trials and is protected by ...
Breaking Biology News(10 mins):India Biometrics Market to Grow at Over 35% Through 2020, Says TechSci Research 2India Biometrics Market to Grow at Over 35% Through 2020, Says TechSci Research 3Cognitive Assessment and Training Market Worth 7.5 Billion USD by 2020 2Cognitive Assessment and Training Market Worth 7.5 Billion USD by 2020 3Cognitive Assessment and Training Market Worth 7.5 Billion USD by 2020 4Sarcos to Debut First-of-its-Kind Snake Robot 2Sarcos to Debut First-of-its-Kind Snake Robot 3
... vapor from the metallic element mercury into the atmosphere each ... being changed into a form that is easily removed from ... and lower stratosphere work to transform elemental mercury into oxidized ... ultimately enter the food chain. "The upper atmosphere is ...
... world of insects, high risk of attack has led ... survival, especially in the larval stage. One caterpillar may ... bird droppings. Though crypsis may have its advantages, University ... evidence of caterpillars using another strategy previously best-known in ...
... whale to a human being, poses a special challenge ... body will die without reproducing; only a privileged few ... How could the extreme degree of cooperation required by ... individualists determined to pass on their own genes? ...
Cached Biology News:Upper atmosphere facilitates changes that let mercury enter food chain 2Caterpillars mimic one another for survival 2Caterpillars mimic one another for survival 3Close family ties keep microbial cheaters in check, study finds 2Close family ties keep microbial cheaters in check, study finds 3Close family ties keep microbial cheaters in check, study finds 4Close family ties keep microbial cheaters in check, study finds 5
... a fully automated microplate based multi-detection ... in academia and industry. The FLUOstar ... Fluorescence Intensity including FRET and ... including DELFIATM High-Performance Luminescence (flash ...
... can operate as a Voltage Clamp, as a ... in electrophysiology research applications. Performance in any one ... • This amazing instrument ... the capabilities of Digital Signal Processing (DSP) integrated ...
... activity is expressed in g per ml and ... saline, pH 6.8, of a 1 mg per ... lowest concentration to agglutinate a 2% suspension of ... incubation at 25 C. Preparation Note: ...
... save space and organize gloves, ... other garb. They are the ... small parts used in labs, ... Open-slot design for easy cleaning. ...
Biology Products: